Insider trading
Officers, directors, and 10% owners buying and selling their own company's stock, from SEC Form 4 filings. Newest first.
Showing the last 10 days.Sign up free for 90 days
| Type | Symbol | Insider | Shares | Price | Value | Traded | Filed |
|---|---|---|---|---|---|---|---|
| Grant | DGX | Doherty Catherine T. Executive Vice President | 4,827 | — | Nov 3, 2026 | Nov 6, 2026 | |
| Exercise | DGX | Doherty Catherine T. Executive Vice President | 22,105 | $2.7M | Nov 3, 2026 | Nov 6, 2026 | |
| Sell | DGX | Doherty Catherine T. Executive Vice President | 22,105 | $5.5M | Nov 3, 2026 | Nov 6, 2026 | |
| Grant | DGX | Delaney Mark E SVP & Chief Commercial Officer | 2,615 | — | Nov 3, 2026 | Nov 6, 2026 | |
| Other | HQ | You Harry L. Director, 10% owner | 1,163,484 | — | Nov 3, 2026 | Nov 5, 2026 | |
| Other | HQ | You Harry L. Director, 10% owner | 1,163,484 | — | Nov 3, 2026 | Nov 5, 2026 | |
| Buy | MXE | Saba Capital Management, L.P. 10% owner | 15,011 | $314K | Nov 4, 2026 | Nov 5, 2026 | |
| Sell | — | Pershing Square Capital Management, L.P. Director, 10% owner | — | — | Nov 3, 2026 | Nov 5, 2026 | |
| Buy | — | Pershing Square Capital Management, L.P. Director, 10% owner | — | — | Nov 3, 2026 | Nov 5, 2026 | |
| Sell | ALMR | Qiming Corporate GP VI, Ltd. 10% owner | 111,313 | $3.3M | Nov 3, 2026 | Nov 5, 2026 | |
| Sell | FMC | Scanlan Jacqueline Executive VP & Chief HRO | 4,930 | $32K | Nov 3, 2026 | Nov 5, 2026 | |
| Sell | SPPL | Soo QiKai Chief Technology Officer | 47,171 | $5.7B | Nov 4, 2026 | Nov 5, 2026 | |
| Sell | NDAQ | Tal Cohen Pres. Market Platforms | 2,289 | $247K | Nov 3, 2026 | Nov 5, 2026 | |
| Gift | SCL | Stepan F Quinn Jr Director | 1,430 | — | Nov 3, 2026 | Nov 5, 2026 | |
| Buy | LBTYA | Rodriguez Enrique EVP, Chief Technology Officer | 211,313 | $2.0M | Nov 4, 2026 | Nov 5, 2026 | |
| Grant | KBR | Qasem Rami Director | 4,410 | — | Nov 2, 2026 | Nov 5, 2026 | |
| Sell | ARQT | Matsuda Masaru EVP, Chief Legal Officer | 41,219 | $1.4M | Nov 4, 2026 | Nov 4, 2026 | |
| Exercise | ARQT | Matsuda Masaru EVP, Chief Legal Officer | 40,000 | $146K | Nov 4, 2026 | Nov 4, 2026 | |
| Sell | ARQT | Burnett Patrick EVP, Chief Medical Officer | 943 | $30K | Nov 2, 2026 | Nov 4, 2026 | |
| Sell | ARQT | Watanabe Todd See Remarks, Director | 4,377 | $139K | Nov 2, 2026 | Nov 4, 2026 | |
| Exercise | NGVC | Isely Raquel M. 13D Group Member | 4,000 | — | Nov 2, 2026 | Nov 4, 2026 | |
| Tax | NGVC | Isely Raquel M. 13D Group Member | 1,147 | $33K | Nov 2, 2026 | Nov 4, 2026 | |
| Exercise | EVER | Mendal Jayme CEO and President, Director | 40,131 | — | Nov 4, 2026 | Nov 4, 2026 | |
| Sell | EVER | Mendal Jayme CEO and President, Director | 20,981 | $501K | Nov 2, 2026 | Nov 4, 2026 | |
| Tax | INFQ | Hart Ilan Chief Financial Officer | 24,365 | $216K | Nov 3, 2026 | Nov 4, 2026 | |
| Buy | MXE | Saba Capital Management, L.P. 10% owner | 13,804 | $284K | Nov 3, 2026 | Nov 4, 2026 | |
| Exercise | BMY | Lenkowsky Adam EVP, Chief Commercial Officer | 7,522 | — | Nov 3, 2026 | Nov 4, 2026 | |
| Tax | BMY | Lenkowsky Adam EVP, Chief Commercial Officer | 3,848 | $237K | Nov 3, 2026 | Nov 4, 2026 | |
| Tax | FEIM | Lord Lance W Director | 4,246 | $220K | Oct 31, 2026 | Nov 4, 2026 | |
| Grant | FEIM | Lord Lance W Director | 1,921 | — | Oct 30, 2026 | Nov 4, 2026 | |
| Tax | FEIM | Schwartz Richard Director | 2,647 | $97K | Oct 31, 2025 | Nov 4, 2026 | |
| Grant | FEIM | Schwartz Richard Director | 1,921 | — | Oct 30, 2026 | Nov 4, 2026 | |
| Grant | NDAQ | Ekholm Borje Director | 1,449 | — | Nov 2, 2026 | Nov 4, 2026 | |
| Exercise | LQDT | Daunt John EVP, Chief Commercial Officer | 715 | $14K | Nov 2, 2026 | Nov 4, 2026 | |
| Sell | LQDT | Daunt John EVP, Chief Commercial Officer | 715 | $32K | Nov 2, 2026 | Nov 4, 2026 | |
| Sell | CNA | Lindquist Scott R EVP & CFO | 23,579 | $1.1M | Nov 3, 2026 | Nov 4, 2026 | |
| Grant | RGCO | Archer Jacqueline L. Director | 245 | $6K | Nov 2, 2026 | Nov 4, 2026 | |
| Buy | GLQ | Kowaleski John E. Director | 260 | $2K | Nov 3, 2026 | Nov 4, 2026 | |
| Grant | ELS | Freedman Constance Director | 76 | $4K | Nov 2, 2026 | Nov 4, 2026 | |
| Buy | MXE | Saba Capital Management, L.P. 10% owner | 200 | $4K | Nov 2, 2026 | Nov 3, 2026 | |
| Exercise | FFIV | Okeke Angelique M EVP, General Counsel | 1,312 | — | Nov 1, 2026 | Nov 3, 2026 | |
| Tax | FFIV | Okeke Angelique M EVP, General Counsel | 1,049 | $355K | Nov 1, 2026 | Nov 3, 2026 | |
| Tax | QLYS | Kim Joo Mi CHIEF FINANCIAL OFFICER | 3,846 | $862K | Nov 1, 2026 | Nov 3, 2026 | |
| Sell | QLYS | Kim Joo Mi CHIEF FINANCIAL OFFICER | 2,659 | $557K | Nov 2, 2026 | Nov 3, 2026 | |
| Tax | QLYS | Posey Bruce K CHIEF LEGAL OFFICER | 2,270 | $509K | Nov 1, 2026 | Nov 3, 2026 | |
| Tax | QLYS | Thakar Sumedh S CEO & PRESIDENT, Director | 6,749 | $1.5M | Nov 1, 2026 | Nov 3, 2026 | |
| Exercise | CVNA | Quayle J Danforth Director | 14,520 | $44K | Oct 30, 2026 | Nov 3, 2026 | |
| Sell | CVNA | Quayle J Danforth Director | 14,520 | $1.0M | Oct 30, 2026 | Nov 3, 2026 | |
| Exercise | LAES | Enguent Jean-Pierre Vice President, R&DSS | 35,000 | $350 | Nov 2, 2026 | Nov 3, 2026 | |
| Sell | LAES | Enguent Jean-Pierre Vice President, R&DSS | 35,000 | $48K | Nov 3, 2026 | Nov 3, 2026 |